hrp0092p2-194 | Growth and Syndromes (to include Turner Syndrome) | ESPE2019
Calliari Luis Eduardo
, Barquero Paula
, Sato Cleber
, Koledova Ekaterina
Previous studies have shown that poor adherence to recombinant human growth hormone (r-hGH; Saizen®) therapy is associated with decreased efficacy outcomes and increased healthcare costs. Easypod is the only electronic injection device that enables continuous monitoring of adherence to treatment. Early recognition of non-adherence is essential in the management of long-term outcomes of r-hGH therapy. This analysis aimed to evaluate adherence to r-hGH therapy adminis...